Microbiome as a biomarker and therapeutic target in pancreatic cancerGhazaleh Pourali, Amir Avan, Danial Kazemi et al.|BMC Microbiology|2024Cited by 50
Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospectiveNima Zafari, Amir Avan, Majid Ghayour‐Mobarhan et al.|Life Sciences|2022Cited by 42
Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancerFatemeh Khojasteh‐Leylakoohi, Amir Avan, Reza Mohit et al.|Scientific Reports|2023Cited by 17
The Potential Diagnostic and Prognostic Value of Circulating MicroRNAs in the Assessment of Patients With Prostate Cancer: Rational and ProgressElham Samami, Amir Avan, Ghazaleh Pourali et al.|Frontiers in Oncology|2022Cited by 13
Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver diseaseElham Nazari, Amir Avan, Ghazaleh Khalili‐Tanha et al.|Scientific Reports|2023Cited by 12